 | • レポートコード：MRC2012A2482 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、CRISPR・CRISPR関連（Cas）遺伝子の世界市場を広く調査・分析し、今後の市場展望をまとめております。CRISPR・CRISPR関連（Cas）遺伝子の種類別市場規模（ゲノム編集、遺伝子エンジニアリング、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株エンジニアリング）、用途別市場規模（バイオテクノロジー企業、製薬企業、学術機関、研究・開発機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Caribou Biosciences、Thermo Fisher Scientific、Merck KGaA、Addgene、Takara Bio USA、CRISPR THERAPEUTICS、Intellia Therapeutics、Editas Medicine、Mirus Bio LLC、Horizon Discovery Group、GE Healthcare Dharmacon、 ・地域別グローバル市場分析 2015年-2020年 ・CRISPR・CRISPR関連（Cas）遺伝子の北米市場（アメリカ、カナダ、メキシコ） ・CRISPR・CRISPR関連（Cas）遺伝子のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・CRISPR・CRISPR関連（Cas）遺伝子のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・CRISPR・CRISPR関連（Cas）遺伝子の南米市場（ブラジル、アルゼンチン） ・CRISPR・CRISPR関連（Cas）遺伝子の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ゲノム編集、遺伝子エンジニアリング、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株エンジニアリング ・用途別分析：バイオテクノロジー企業、製薬企業、学術機関、研究・開発機関 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The CRISPR And CRISPR-Associated (Cas) Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global CRISPR And CRISPR-Associated (Cas) Genes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 38.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 2685.5 million by 2025, from USD 734.5 million in 2019.
Market segmentation
CRISPR And CRISPR-Associated (Cas) Genes market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, CRISPR And CRISPR-Associated (Cas) Genes market has been segmented into
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Application, CRISPR And CRISPR-Associated (Cas) Genes has been segmented into:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global CRISPR And CRISPR-Associated (Cas) Genes market presented in the report. This section sheds light on the sales growth of different regional and country-level CRISPR And CRISPR-Associated (Cas) Genes markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CRISPR And CRISPR-Associated (Cas) Genes market.
The report offers in-depth assessment of the growth and other aspects of the CRISPR And CRISPR-Associated (Cas) Genes market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and CRISPR And CRISPR-Associated (Cas) Genes Market Share Analysis
CRISPR And CRISPR-Associated (Cas) Genes competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CRISPR And CRISPR-Associated (Cas) Genes sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CRISPR And CRISPR-Associated (Cas) Genes sales, revenue and market share for each player covered in this report.
The major players covered in CRISPR And CRISPR-Associated (Cas) Genes are:
Caribou Biosciences
Thermo Fisher Scientific
Merck KGaA
Addgene
Takara Bio USA
CRISPR THERAPEUTICS
Intellia Therapeutics
Editas Medicine
Mirus Bio LLC
Horizon Discovery Group
GE Healthcare Dharmacon
Among other players domestic and global, CRISPR And CRISPR-Associated (Cas) Genes market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe CRISPR And CRISPR-Associated (Cas) Genes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of CRISPR And CRISPR-Associated (Cas) Genes, with price, sales, revenue and global market share of CRISPR And CRISPR-Associated (Cas) Genes in 2018 and 2019.
Chapter 3, the CRISPR And CRISPR-Associated (Cas) Genes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the CRISPR And CRISPR-Associated (Cas) Genes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, CRISPR And CRISPR-Associated (Cas) Genes market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe CRISPR And CRISPR-Associated (Cas) Genes sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 CRISPR And CRISPR-Associated (Cas) Genes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market Analysis by Application
1.3.1 Overview: Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Overview of Global CRISPR And CRISPR-Associated (Cas) Genes Market
1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business
2.1.3 Caribou Biosciences SWOT Analysis
2.1.4 Caribou Biosciences Product and Services
2.1.5 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA SWOT Analysis
2.3.4 Merck KGaA Product and Services
2.3.5 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Addgene
2.4.1 Addgene Details
2.4.2 Addgene Major Business
2.4.3 Addgene SWOT Analysis
2.4.4 Addgene Product and Services
2.4.5 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takara Bio USA
2.5.1 Takara Bio USA Details
2.5.2 Takara Bio USA Major Business
2.5.3 Takara Bio USA SWOT Analysis
2.5.4 Takara Bio USA Product and Services
2.5.5 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 CRISPR THERAPEUTICS
2.6.1 CRISPR THERAPEUTICS Details
2.6.2 CRISPR THERAPEUTICS Major Business
2.6.3 CRISPR THERAPEUTICS Product and Services
2.6.4 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intellia Therapeutics
2.7.1 Intellia Therapeutics Details
2.7.2 Intellia Therapeutics Major Business
2.7.3 Intellia Therapeutics Product and Services
2.7.4 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Editas Medicine
2.8.1 Editas Medicine Details
2.8.2 Editas Medicine Major Business
2.8.3 Editas Medicine Product and Services
2.8.4 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mirus Bio LLC
2.9.1 Mirus Bio LLC Details
2.9.2 Mirus Bio LLC Major Business
2.9.3 Mirus Bio LLC Product and Services
2.9.4 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Horizon Discovery Group
2.10.1 Horizon Discovery Group Details
2.10.2 Horizon Discovery Group Major Business
2.10.3 Horizon Discovery Group Product and Services
2.10.4 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 GE Healthcare Dharmacon
2.11.1 GE Healthcare Dharmacon Details
2.11.2 GE Healthcare Dharmacon Major Business
2.11.3 GE Healthcare Dharmacon Product and Services
2.11.4 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Manufacturer (2018-2019)
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2019
3.3.2 Top 6 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions
4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Regions (2015-2020)
4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Regions (2015-2020)
4.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
4.5 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country
5.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2015-2020)
5.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2015-2020)
5.2 United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
5.3 Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
5.4 Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country
6.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2015-2020)
6.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2015-2020)
6.2 Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
6.3 UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
6.4 France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
6.5 Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
6.6 Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Regions (2015-2020)
7.2 China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7.3 Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7.4 Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7.5 India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7.6 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
7.7 Australia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country
8.1.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2015-2020)
8.1.2 South America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2015-2020)
8.2 Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
8.3 Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
9.3 Turkey CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
9.4 Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
9.5 South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Market Share by Type (2015-2020)
10.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2015-2020)
10.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Type (2015-2020)
11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment by Application
11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application (2015-2020)
11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2015-2020)
11.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price by Application (2015-2020)
12 Market Forecast
12.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue and Growth Rate (2021-2025)
12.2 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Regions (2021-2025)
12.2.1 North America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025)
12.2.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025)
12.2.3 Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025)
12.2.4 South America CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025)
12.2.5 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025)
12.3 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Type (2021-2025)
12.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2021-2025)
12.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2021-2025)
12.4 CRISPR And CRISPR-Associated (Cas) Genes Market Forecast by Application (2021-2025)
12.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2021-2025)
12.4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CRISPR And CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CRISPR And CRISPR-Associated (Cas) Genes Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Caribou Biosciences Basic Information, Manufacturing Base and Competitors
Table 9. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 10. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 11. Caribou Biosciences SWOT Analysis
Table 12. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 13. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 15. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 16. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 17. Thermo Fisher Scientific SWOT Analysis
Table 18. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 19. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 21. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 22. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 23. Merck KGaA SWOT Analysis
Table 24. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 25. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Addgene Basic Information, Manufacturing Base and Competitors
Table 27. Addgene CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 28. Addgene CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 29. Addgene SWOT Analysis
Table 30. Addgene CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 31. Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Takara Bio USA Basic Information, Manufacturing Base and Competitors
Table 33. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 34. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 35. Takara Bio USA SWOT Analysis
Table 36. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 37. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. CRISPR THERAPEUTICS Basic Information, Manufacturing Base and Competitors
Table 39. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 40. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 41. CRISPR THERAPEUTICS SWOT Analysis
Table 42. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 43. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Intellia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 45. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 46. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 47. Intellia Therapeutics SWOT Analysis
Table 48. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 49. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Editas Medicine Basic Information, Manufacturing Base and Competitors
Table 51. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 52. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 53. Editas Medicine SWOT Analysis
Table 54. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 55. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Mirus Bio LLC Basic Information, Manufacturing Base and Competitors
Table 57. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 58. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 59. Mirus Bio LLC SWOT Analysis
Table 60. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 61. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Horizon Discovery Group Basic Information, Manufacturing Base and Competitors
Table 63. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 64. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 65. Horizon Discovery Group SWOT Analysis
Table 66. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 67. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. GE Healthcare Dharmacon Basic Information, Manufacturing Base and Competitors
Table 69. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Major Business
Table 70. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Total Revenue (USD Million) (2018-2019)
Table 71. GE Healthcare Dharmacon SWOT Analysis
Table 72. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Product and Services
Table 73. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturer (2018-2019) (K Units)
Table 75. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Regions (2015-2020) (K Units)
Table 77. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Regions (2015-2020)
Table 78. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Regions (2015-2020) (USD Million)
Table 79. North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2015-2020) (K Units)
Table 80. North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries (2015-2020)
Table 81. North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2015-2020) (USD Million)
Table 82. North America CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020)
Table 83. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2015-2020) (K Units)
Table 84. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries (2015-2020)
Table 85. Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Regions (2015-2020) (K Units)
Table 87. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Regions (2015-2020) (USD Million)
Table 89. South America CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2015-2020) (K Units)
Table 90. South America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries (2015-2020)
Table 91. South America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2015-2020) (USD Million)
Table 92. South America CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Countries (2015-2020) (K Units)
Table 94. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020)
Table 97. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Type (2015-2020) (K Units)
Table 98. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Type (2015-2020)
Table 99. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type (2015-2020) (USD Million)
Table 100. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Type (2015-2020)
Table 101. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Application (2015-2020) (K Units)
Table 102. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Share by Application (2015-2020)
Table 103. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Regions (2021-2025) (K Units)
Table 104. Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Regions (2021-2025)
Table 105. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2021-2025) (K Units)
Table 106. Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Type (2021-2025)
Table 107. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2021-2025)
Table 108. Global CRISPR And CRISPR-Associated (Cas) Genes Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. CRISPR And CRISPR-Associated (Cas) Genes Picture
Figure 2. Global Sales Market Share of CRISPR And CRISPR-Associated (Cas) Genes by Type in 2019
Figure 3. Genome Editing Picture
Figure 4. Genetic engineering Picture
Figure 5. gRNA Database/Gene Librar Picture
Figure 6. CRISPR Plasmid Picture
Figure 7. Human Stem Cells Picture
Figure 8. Genetically Modified Organisms/Crops Picture
Figure 9. Cell Line Engineering Picture
Figure 10. CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Application in 2019
Figure 11. Biotechnology Companies Picture
Figure 12. Pharmaceutical Companies Picture
Figure 13. Academic Institutes Picture
Figure 14. Research and Development Institutes Picture
Figure 15. Global CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey CRISPR And CRISPR-Associated (Cas) Genes Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Manufacturer in 2019
Figure 36. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 CRISPR And CRISPR-Associated (Cas) Genes Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 41. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Regions (2015-2020)
Figure 43. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Regions in 2018
Figure 44. North America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
Figure 45. Europe CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
Figure 47. South America CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020)
Figure 49. North America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries (2015-2020)
Figure 51. North America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries in 2018
Figure 52. North America CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries in 2018
Figure 54. United States CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Canada CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Mexico CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020)
Figure 59. Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries in 2019
Figure 60. Germany CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 61. UK CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 62. France CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Russia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Italy CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Regions 2019
Figure 67. Asia-Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Regions 2019
Figure 68. China CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Japan CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Korea CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 71. India CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 73. South America CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries in 2019
Figure 75. South America CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries in 2019
Figure 76. Brazil CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Argentina CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Egypt CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Turkey CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 85. South Africa CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2015-2020) (K Units)
Figure 86. Global CRISPR And CRISPR-Associated (Cas) Genes Sales and Growth Rate (2021-2025) (K Units)
Figure 87. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025) (K Units)
Figure 89. Europe Sales CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025) (K Units)
Figure 90. Asia-Pacific Sales CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025) (K Units)
Figure 91. South America Sales CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025) (K Units)
Figure 92. Middle East & Africa Sales CRISPR And CRISPR-Associated (Cas) Genes Market Forecast (2021-2025) (K Units)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
CRISPR・Cas遺伝子の世界市場（～2026年） CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to d…- CRISPR・Cas遺伝子の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The CRISPR & Cas Genes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- ゲノム編集/ゲノム工学の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Genome Editing/Genome Engineering market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.9% in the forecast period of 2020 to 2025 and will expected to reach USD 4759.2 million by 2025, from USD 3386.9 million in 2019. The Ge…
- 遺伝子編集の世界市場（～2026年） Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication th…
- ゲノム編集の世界市場（～2026年） Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific doub…